A new protocol developed in Sweden has the potential for industrial-scale production of the brain helper cells known as astrocytes. The research team's work could help medical science develop treatments for such diseases as Alzheimer’s.
Europe is on a quest to make renewable energy available to remote coastal areas and islands. That’s the motivation behind the testing of a powerful Swedish-designed wave energy conversion system in the North Atlantic.
KTH researchers reported a nanoengineering innovation that offers hope for treatment of cancer, infections and other health problems – conductive wires of DNA enhanced with gold which could be used to electrically measure hundreds of biological processes simultaneously.
On 1st January 2018, KTH will be launching a new structure which will see five schools replacing the previous ten.
“We are creating a structure that will provide more efficient and clearer support for our academic excellence and better reflect KTH’s breadth and expertise,” says KTH President Sigbritt Karlsson.
Recently, the European Research Council (ERC) published the results of the 2017 call for proposals for ERC Consolidator Grants. Of the total of 14 Swedish researchers who received grants, two are from KTH Royal Institute of Technology: Dejan Kostic, Professor of Internetworking and Per Högselius, Associate Professor in the field of the History of Science, Technology and Environment.
Researchers from KTH have succeeded in taking the next step toward using man-made nanoscale compounds in the fight against cancer. A recent proof-of-concept study showed that dendrimers – which were first introduced in the 1980s – may be used to introduce compounds that essentially trick cancer cells into performing self-destructive tasks.
With recent advances, technology can be used to synthesize silk with similar mechanical properties as an actual spider’s. But applying this material to promising medical therapies for illnesses such as cancer requires that humans develop a capability that only arachnids or silkworms possess – the ability to control the formation of silk.
The UN’s 17 Sustainable Development Goals are aimed at achieving equality, securing global peace and ending extreme poverty – an ambitious agenda that will require a wide-range of conditions to be met. But one requirement lies at the center of most of the SDGs: that people have access to clean, affordable energy, says a new study co-authored by Francesco Fuso Nerini, Assistant Professor in the Division of Energy Systems Analysis at KTH.
The future of secure communication will be in quantum encryption, and KTH will lead research in this area under the auspices of a new national research center financed by the Knut and Alice Wallenberg Foundation.
Imagine an industrial setting. A team of robots has been given the task of transporting boxes from one place to another, but (!) a truck has mistakenly put a huge delivery in front of them. An error of this kind would cause the system to halt, require human intervention and restarting. But this could soon be about to change.
Harnessing the Sun’s radiation to help rid the oceans of microplastic contamination is one of several technical innovations to be developed by a new EU-funded project. Beginning in November 2017, a system developed at KTH Royal Institute of Technology in Sweden for breaking down microplastics from personal care products will be tested for implementation in homes and wastewater treatment plants.
The Human Protein Atlas and Cell Atlas projects at KTH Royal Institute of Technology’s Science for Life Laboratory (SciLifeLab) are teaming up with the Chan Zuckerberg Initiative to strengthen research in cell biology and proteomics.
An advanced robot that can perform high precision surgery. Automated patient voice analysis as a method for medical diagnosis and individual treatment. Swedish and Japanese researchers can now start to work more closely together in areas like this to tackle the challenges of an ageing population.
There have been huge advances in medical science since Robert Hooke coined the term “cell” in 1665, yet the cells of the human body remain a mystery. KTH researcher Emma Lundberg is one of the scientists behind efforts to solve the puzzle of how cells work and ultimately to find new ways to treat disease.
Humanity’s origins, protein mapping and the neurobiology of the world’s deadliest animal, the mosquito, are some of the topics addressed by a group of cutting-edge scientists at a life sciences symposium in Stockholm on 15 September. The symposium is a part of the centenary celebrations of the Knut and Alice Wallenberg Foundation.
There may no silver bullet for treating liver cancer or fatty liver disease, but knowing the right targets will help science develop the most effective treatments. KTH researchers have just identified a number of drug targets that can be used in the development of new efficient treatment strategies with minimum side effects.